Cargando…

Targeted therapies in advanced biliary tract cancers—a narrative review

BACKGROUND AND OBJECTIVE: Biliary tract cancers (BTCs), including cholangiocarcinoma and gallbladder cancer, are a relatively rare group of cancers with a poor prognosis. Over the past decade, the utilization of next-generation sequencing has led to the identification of multiple actionable somatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	LaPelusa, Michael, Heumann, Thatcher, Goff, Laura, Agarwal, Rajiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175163/ https://www.ncbi.nlm.nih.gov/pubmed/36946186 http://dx.doi.org/10.21037/cco-22-93

Ejemplares similares

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
por: Lo, Justin H., et al.
Publicado: (2023)

Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review
por: Chamseddine, Shadi, et al.
Publicado: (2023)

Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements
por: Cann, Christopher G., et al.
Publicado: (2023)

Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review
por: Wang, Yaoqun, et al.
Publicado: (2023)

Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

An aberrant reaction to Candida albicans antigen used for recalcitrant warts successfully treated with oral prednisone
por: La'Pelusa, Andrew, et al.
Publicado: (2018)

Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011)

Targeted Therapy in Biliary Tract Cancers
por: Merla, Amartej, et al.
Publicado: (2015)

Cross-border utilization of cancer care by patients in the US and Mexico – a survey of Mexican oncologists
por: LaPelusa, Michael, et al.
Publicado: (2023)

Combination Therapies for Advanced Biliary Tract Cancer
por: Zeng, Weifeng, et al.
Publicado: (2023)

Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis
por: Bai, Xue-Song, et al.
Publicado: (2022)

Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza
por: Queiroz, Marcello Moro, et al.
Publicado: (2023)

Durvalumab: A Review in Advanced Biliary Tract Cancer
por: Fung, Simon, et al.
Publicado: (2023)

Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer
por: LaPelusa, Michael, et al.
Publicado: (2022)

Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021)

Toripalimab in advanced biliary tract cancer
por: Li, Wei, et al.
Publicado: (2022)

Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview
por: Yang, Wenwei, et al.
Publicado: (2021)

Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective †
por: Tam, Vincent C., et al.
Publicado: (2022)

Trends in the Incidence and Treatment of Early-Onset Pancreatic Cancer
por: LaPelusa, Michael, et al.
Publicado: (2022)

Adjuvant therapy of biliary tract cancers
por: Kefas, Joanna, et al.
Publicado: (2023)

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Current options and future directions of systemic therapy for advanced biliary tract cancer
por: Prete, Maria Giuseppina, et al.
Publicado: (2021)

EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs
por: Cai, Wen, et al.
Publicado: (2018)

Precision Oncology Targets in Biliary Tract Cancer
por: Farha, Nicole, et al.
Publicado: (2023)

mTOR Inhibitors in Advanced Biliary Tract Cancers
por: Wu, Chao-En, et al.
Publicado: (2019)

Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
por: Kang, Sandra, et al.
Publicado: (2022)

Main causes of death in advanced biliary tract cancer
por: Kimura‐Seto, Kana, et al.
Publicado: (2023)

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?
por: Aimar, Giacomo, et al.
Publicado: (2021)

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
por: Park, Joon Oh, et al.
Publicado: (2015)

Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer
por: Sun, Danyang, et al.
Publicado: (2019)

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma
por: Wang, Yunchao, et al.
Publicado: (2022)

Horizons on the Therapy of Biliary Tract Cancers: A State-of-the-art Review
por: Xue, Ran, et al.
Publicado: (2021)

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers
por: Goff, Laura W., et al.
Publicado: (2016)

Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and Outcomes
por: Gray, Simon, et al.
Publicado: (2023)

Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
por: Simone, Valeria, et al.
Publicado: (2017)

Current status of chemotherapy for the treatment of advanced biliary tract cancer
por: Sasaki, Takashi, et al.
Publicado: (2013)

Therapeutic implication of HER2 in advanced biliary tract cancer
por: Nam, Ah-Rong, et al.
Publicado: (2016)

Prognostic Significance of Sarcopenia in Advanced Biliary Tract Cancer Patients
por: Lee, Byung min, et al.
Publicado: (2020)

Quality of Life and Symptom Management in Advanced Biliary Tract Cancers
por: Hunter, Lindsay A., et al.
Publicado: (2021)

Advances in the systemic treatment of therapeutic approaches in biliary tract cancer
por: Mirallas, O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2n9pmgrln1re16um7mu8u2mveq